These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7650803)

  • 1. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?
    Grover SA; Coupal L; Hu XP
    JAMA; 1995 Sep; 274(10):801-6. PubMed ID: 7650803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines.
    Grover SA; Dorais M; Paradis G; Fodor JG; Frohlich JJ; McPherson R; Coupal L; Zowall H
    CMAJ; 2000 Nov; 163(10):1263-9. PubMed ID: 11107461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort.
    Grover SA; Palmer CS; Coupal L
    Arch Intern Med; 1994 Mar; 154(6):679-84. PubMed ID: 8129502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.
    Connelly PW; MacLean DR; Horlick L; O'Connor B; Petrasovits A; Little JA
    CMAJ; 1992 Jun; 146(11):1977-87. PubMed ID: 1596847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for total cholesterol. Do the National Cholesterol Education Program's recommendations detect individuals at high risk of coronary heart disease?
    Bush TL; Riedel D
    Circulation; 1991 Apr; 83(4):1287-93. PubMed ID: 2013146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for coronary heart disease risk in the elderly: total cholesterol versus high-density lipoprotein-cholesterol.
    Kligman EW; Watkins AJ
    Am J Prev Med; 1991; 7(5):263-7. PubMed ID: 1790030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study.
    Castelli WP
    Can J Cardiol; 1988 Jul; 4 Suppl A():5A-10A. PubMed ID: 3179802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes.
    Avins AL; Browner WS
    JAMA; 1998 Feb; 279(6):445-9. PubMed ID: 9466637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid abnormalities in coronary heart disease: a population-based case-control study.
    Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP
    Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
    Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
    Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
    Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
    Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.